Bloomberg Law Reports
Anti‐Commercial Bribery Laws in China and Their Enforcement in the Pharmaceutical Industry
November 2010
Anti‐commercial bribery laws have a huge impact on the daily business operation of companies in China. At present, relevant laws and regulations in China are very general and vague and, as a result, enforcement agencies at local levels have a great deal of discretion in determining what types of activities constitute commercial bribery, and what penalties will be imposed.
Contacts
Capabilities
Suggested News & Insights
Bay Area General Counsel RoundtableThursday, September 24, 2026New York Ethics Opinion Addresses Ethical Limits on Attorney Participation in Whistleblower InvestigationsJuly 30, 2026DOJ Grants First Healthcare Declination Under New Corporate Enforcement Policy While Indicting FounderJuly 30, 2026Laboratory, Owners, and Investors Settle COVID-19 Testing Fraud Allegations for $24 MillionJuly 27, 2026Laboratory, Owners, and Investors Settle COVID-19 Testing Fraud Allegations for $24 MillionJuly 27, 2026DOJ Expands Trade Fraud Enforcement After $1 Billion MilestoneJuly 24, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory